Why the study?
What is the prevalence and clinical significance of macro CK type 1 in patients undergoing CK isoenzyme analysis?
What is the prevalence and clinical significance of macro CK type 1 in patients undergoing CK isoenzyme analysis?
Macro CK type 1 is a rare serum marker (0.61% prevalence) that is associated with older age, female sex, and cardiovascular disease complications.
The prevalence of circulating macromolecular creatine kinase type 1 (macro CK type 1 or CK-immunoglobulin complexes) is significantly higher in a patient population selected for CK isoenzyme assay than in age- and sex-matched blood donors (n = 1304). In greater than 8000 patients studied, 49 individuals with macro CK type 1 were identified, yielding an overall prevalence of 0.61%. Macro CK type 1 complexes occurred more frequently in women and in patients older than 70 years, and were often associated with complications of cardiovascular disease, life-threatening conditions, and poor outcome. These latter clinical associations could arise, at least partly, from the selection of patients for whom CK isoenzyme analysis was ordered.
No takes yet. Share an insight, caveat, or question.
Laureys et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: